| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―21 |
Identifying microRNA expression alterations in erythrocytes, lymphocytes, and monocytes during severe COVID-19 |
A. A. Artamonov, Yu. V. Nikitin, A. A. Velmiskina, S. V. Mosenko, V. S. Shimansky, A. Yu. Asinovskaya, et al. (+5) S. V. Apalko, N. N. Sushentseva, A. M. Ivanov, S. G. Scherbak, K. A. Kondratov |
| 2 |
[GO] |
2025―Dec―23 |
The parameters of long-term humoral immunity induced by a single injection of the Sputnik Light vaccine among non-infected volunteers and those infected with SARS-CoV-2 |
F. M. Izhaeva, A. I. Tukhvatulin, A. S. Dzharullaeva, I. V. Dolzhikova, O. V. Zubkova, D. V. Shcheblyakov, et al. (+11) N. L. Lubenets, E. A. Smolyarchuk, T. G. Zubkova, A. S. Erokhova, I. М. Cherenkova, К. М. Bukhtin, O. Popova, N. M. Tukhvatulina, B. S. Naroditsky, D. Y. Logunov, A. L. Gintsburg |
| 3 |
[GO] |
2024―Aug―22 |
Ceramides As Potential New Predictors of the Severity of Acute Coronary Syndrome in Conjunction with SARS-CoV-2 Infection |
N. G. Lozhkina, O. I. Gushchina, N. V. Basov, E. V. Gaisler, A. D. Rogachev, Yu. S. Sotnikova, et al. (+2) Yu. V. Patrushev, A. G. Pokrovsky |
| 4 |
[GO] |
2024―Jan―19 |
<i>In Vitro</i> Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2 |
A. N. Narovlyansky, M. V. Filimonova, N. G. Tsyshkova, A. V. Pronin, T. V. Grebennikova, E. V. Karamov, et al. (+26) V. F. Larichev, G. V. Kornilayeva, I. T. Fedyakina, I. V. Dolzhikova, M. V. Mezentseva, E. I. Isaeva, V. V. Poloskov, L. S. Koval, V. P. Marinchenko, V. I. Surinova, A. S. Filimonov, A. A. Shitova, O. V. Soldatova, A. V. Sanin, I. K. Zubashev, A. V. Ponomarev, V. V. Veselovsky, V. V. Kozlov, A. V. Stepanov, A. V. Khomich, V. S. Kozlov, S. A. Ivanov, P. V. Shegai, A. D. Kaprin, F. I. Ershov, A. L. Gintsburg |
| 5 |
[GO] |
2023―May―03 |
Characterization of the C6D7-RBD Human Monoclonal Antibody Specific to the SARS-CoV-2 S Protein Receptor-Binding Domain |
Yana O. Romanenko, Marina V. Silkina, Alena S. Kartseva, Maksim A. Marin, Maria A. Shkuratova, Maria A. Makarova, et al. (+6) Alena K. Ryabko, Daria A. Konyshkova, Natalia A. Zeninskaya, Anna E. Khlyntseva, Igor G. Shemyakin, Victoria V. Firstova |
| 6 |
[GO] |
2023―Jan―21 |
The Fallout of Catastrophic Technogenic Emissions of Toxic Gases Can Negatively Affect Covid-19 Clinical Course |
Giancarlo Succi, Witold Pedrycz, Anna P. Bogachuk, Alexander G. Tormasov, Alexey A. Belogurov, Aldo Spallone |
| 7 |
[GO] |
2022―Oct―29 |
An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity |
Nikita N. Kostin, Tatiana V. Bobik, George A. Skryabin, Mariya A. Simonova, Vera D. Knorre, Victoria A. Abrikosova, et al. (+7) Yuliana A. Mokrushina, Ivan V. Smirnov, Natalia L. Aleshenko, Natalia A. Kruglova, Dmitry V. Mazurov, Alexey E. Nikitin, Alexander G. Gabibov |
| 8 |
[GO] |
2022―Jan―27 |
Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2 |
Elena S. Matyugina, Mikhail S. Novikov, Liubov I. Kozlovskaya, Victor P. Volok, Elena Y. Shustova, Aidar A. Ishmukhametov, et al. (+2) Sergey N. Kochetkov, Anastasia L. Khandazhinskaya |
| 9 |
[GO] |
2021―Nov―15 |
Pathogenesis, Diagnosis, and Treatment of Hemostatic Disorders in COVID-19 Patients |
Airat F. Khalirakhmanov, Kamilla F. Idrisova, Raushaniya F. Gajfullina, Sergey V. Zinchenko, Rustem I. Litvinov, Aydar Z. Sharafeev, et al. (+2) Andrey P. Kiyasov, Albert A. Rizvanov |
| 10 |
[GO] |
2021―Nov―15 |
Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-2 |
Aleksandra A. Nikonova, Eugene B. Faizuloev, Anastasia V. Gracheva, Igor Yu. Isakov, Vitaly V. Zverev |
| 11 |
[GO] |
2021―Apr―21 |
COVID-19 in Russia: Clinical and Immunological Features of the First-Wave Patients |
Tatiana V. Bobik, N. N. Kostin, G. A. Scriabin, P. N. Tsabai, M. A. Simonova, Vera D. Knorre, et al. (+9) O. N. Stratienko, N. L. Aleshchenko, I. I. Vorobiev, E. N. Khurs, Yu. A. Mokrushina, Ivan V. Smirnov, A. I. Alekhin, A. E. Nikitin, Alexander G. Gabibov |
| 12 |
[GO] |
2020―Oct―27 |
Preclinical studies of immunogenity, protectivity, and safety of the combined vector vaccine for prevention of the middle east respiratory syndrome |
Inna V. Dolzhikova, D. M. Grousova, O. V. Zubkova, A. I. Tukhvatulin, A. V. Kovyrshina, N. L. Lubenets, et al. (+17) T. A. Ozharovskaia, O. Popova, I. B. Esmagambetov, D. V. Shcheblyakov, I. M. Evgrafova, A. A. Nedorubov, I. V. Gordeichuk, S. A. Gulyaev, A. G. Botikov, L. V. Panina, D. V. Mishin, S. Y. Loginova, S. V. Borisevich, P. G/ Deryabin, B. S. Naroditsky, D. Y. Logunov, A. L. Gintsburg |
|
